Background:
Mean platelet volume (MPV), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have all been investigated as novel inflammatory markers of cardiac and oncological diseases, while there is only a limited number of studies investigating these markers in chronic obstructive pulmonary disease (COPD). In the present study we examine NLR, PLR; and other markers, such as eosinophil, MPV, plateletcrit (PCT), platelet distribution width (PDW), red cell distribution width (RDW), and C-reactive protein (CRP) in patients with stable and acute exacerbation of COPD.
Methods:
Stable COPD (Group 1, n=140), COPD with acute exacerbation (Group 2, n=110), and healthy controls (Group 3, n=50) were included in the study. Leukocyte, CRP, hemoglobin (HB), RDW, platelet, MPV, PCT, PDW, neutrophil, lymphocyte, eosinophil, NLR, and PLR were analyzed in all groups.
Results:
HB, leukocyte, platelet, neutrophil, eosinophil, MPV, PCT, CRP, NLR, and PLR were significantly higher, while the lymphocyte was lower in Group 1 than in Group 3. Leukocyte, neutrophil, RDW, CRP, NLR, and PLR were significantly higher, while lymphocyte was lower in Group 2 than in Group 3. Leukocyte, neutrophil, RDW, CRP, NLR, and PLR were significantly higher, while HB, platelet, MPV, PCT, and lymphocyte were significantly lower in Group 2 than in Group 1. NLR and PLR increased significantly in patients with bronchiectasis when compared to those without in Group 1.
Conclusions:
Our study results suggest that NLR, PLR and RDW can be used as simple and cost-effective markers for the evaluation of severity of exacerbation and for predicting hospitalization and further exacerbations in patients with COPD.
Citing Articles
The Biomarker Potential of the Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Vaishnav B, Pailla R, Wadivkar A, Ummaleti H, Doshi N
Cureus. 2024; 16(8):e66750.
PMID: 39268318
PMC: 11391329.
DOI: 10.7759/cureus.66750.
Relationship Between Systemic Immune-Inflammation Index and Risk of Respiratory Failure and Death in COPD: A Retrospective Cohort Study Based on the MIMIC-IV Database.
Zhang Y, Tan X, Hu S, Cui Z, Chen W
Int J Chron Obstruct Pulmon Dis. 2024; 19:459-473.
PMID: 38404653
PMC: 10888109.
DOI: 10.2147/COPD.S446364.
Single-cell immunophenotyping revealed the association of CD4+ central and CD4+ effector memory T cells linking exacerbating chronic obstructive pulmonary disease and NSCLC.
Gemes N, Balog J, Neuperger P, Schlegl E, Barta I, Fillinger J
Front Immunol. 2024; 14:1297577.
PMID: 38187374
PMC: 10770259.
DOI: 10.3389/fimmu.2023.1297577.
Association of Red Cell Index and Hospital Mortality in Chronic Obstructive Pulmonary Disease Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study.
Shi Y, Shi Y, Xu Z, Wang Y
Int J Chron Obstruct Pulmon Dis. 2023; 18:2267-2276.
PMID: 37868623
PMC: 10588751.
DOI: 10.2147/COPD.S427433.
Effects of doxofylline as an adjuvant on severe exacerbation and long-term prognosis for COPD with different clinical subtypes.
Chen M, He W, Huang D, Jia H, Zhong Z, Li N
Clin Respir J. 2023; 17(9):851-864.
PMID: 37562435
PMC: 10500324.
DOI: 10.1111/crj.13670.
The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer.
Ma A, Wang G, Du Y, Guo W, Guo J, Hu Y
Front Oncol. 2022; 12:902955.
PMID: 36237340
PMC: 9552820.
DOI: 10.3389/fonc.2022.902955.
The Emerging Clinical Significance of the Red Cell Distribution Width as a Biomarker in Chronic Obstructive Pulmonary Disease: A Systematic Review.
Zinellu A, Mangoni A
J Clin Med. 2022; 11(19).
PMID: 36233510
PMC: 9571455.
DOI: 10.3390/jcm11195642.
Association of Red Cell Index and Adverse Hospitalization Outcomes in Chronic Obstructive Pulmonary Disease Patients with Acute Exacerbation: A Retrospective Cohort Study.
Yuan F, Shui W, Xing Y, Niu Y, Zhang X, Zhang C
Int J Chron Obstruct Pulmon Dis. 2022; 17:2263-2275.
PMID: 36133737
PMC: 9484768.
DOI: 10.2147/COPD.S373114.
A retrospective correlative profiling of lung functions, microbiological, radiological, periodontal, hematological parameters in noncystic fibrosis bronchiectasis patients of North India.
Gupta A, Verma U, Verma A, Chaudhary S, Lal N, Singh N
Natl J Maxillofac Surg. 2022; 13(1):44-53.
PMID: 35911797
PMC: 9326207.
DOI: 10.4103/njms.njms_386_21.
Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism.
Siddiqui F, Garcia-Ortega A, Kantarcioglu B, Sinacore J, Tafur A, Demelo-Rodriguez P
Clin Appl Thromb Hemost. 2022; 28:10760296221113346.
PMID: 35866197
PMC: 9310273.
DOI: 10.1177/10760296221113346.
Association of baseline parameters with year 0 and year 1 acute exacerbations in male patients with chronic obstructive pulmonary disease.
Chang Y, Chen Y, Chang Y, Liu S, Fang W, Chao T
Int J Immunopathol Pharmacol. 2022; 36:3946320221099073.
PMID: 35594865
PMC: 9251822.
DOI: 10.1177/03946320221099073.
Influence of disease severity, smoking status and therapy regimes on leukocyte subsets and their ratios in stable chronic obstructive pulmonary disease.
Hlapcic I, Vukic Dugac A, Popovic-Grle S, Markelic I, Rako I, Rogic D
Arch Med Sci. 2022; 18(3):672-681.
PMID: 35591846
PMC: 9103492.
DOI: 10.5114/aoms.2020.100720.
Circulating Complement C1q as a Novel Biomarker is Associated with the Occurrence and Development of COPD.
Zhang K, Han K, Liu H, Zheng C
Int J Chron Obstruct Pulmon Dis. 2022; 17:395-404.
PMID: 35237032
PMC: 8883408.
DOI: 10.2147/COPD.S347607.
What Are the Most Effective Factors in Determining Future Exacerbations, Morbidity Weight, and Mortality in Patients with COPD Attack?.
Koc C, Sahin F
Medicina (Kaunas). 2022; 58(2).
PMID: 35208487
PMC: 8880362.
DOI: 10.3390/medicina58020163.
Characteristics of length of stay and cardiovascular pharmacotherapy advice among chronic obstructive pulmonary disease patients.
Fang H, Zhang M, Zhao C, Yao X, Wang H, Xia H
Sci Prog. 2021; 104(4):368504211066003.
PMID: 34907809
PMC: 10450607.
DOI: 10.1177/00368504211066003.
ΔRDW: A Novel Indicator with Predictive Value for the Diagnosis and Treatment of Multiple Diseases.
Wang J, Xiao Q, Li Y
Int J Gen Med. 2021; 14:8667-8675.
PMID: 34849010
PMC: 8627260.
DOI: 10.2147/IJGM.S339945.
Pulmonary embolism with chronic obstructive pulmonary disease.
Yang R, Liu G, Deng C
Chronic Dis Transl Med. 2021; 7(3):149-156.
PMID: 34505015
PMC: 8413125.
DOI: 10.1016/j.cdtm.2021.04.001.
Emergency admission parameters for predicting in-hospital mortality in patients with acute exacerbations of chronic obstructive pulmonary disease with hypercapnic respiratory failure.
Chen L, Chen L, Zheng H, Wu S, Wang S
BMC Pulm Med. 2021; 21(1):258.
PMID: 34362328
PMC: 8349105.
DOI: 10.1186/s12890-021-01624-1.
Two new inflammatory markers related to the CURB-65 score for disease severity in patients with community-acquired pneumonia: The hypersensitive C-reactive protein to albumin ratio and fibrinogen to albumin ratio.
Luo B, Sun M, Huo X, Wang Y
Open Life Sci. 2021; 16(1):84-91.
PMID: 33817301
PMC: 7874604.
DOI: 10.1515/biol-2021-0011.
Relationship of Red Cell Index with the Severity of Chronic Obstructive Pulmonary Disease.
Huang Y, Wang J, Shen J, Ma J, Miao X, Ding K
Int J Chron Obstruct Pulmon Dis. 2021; 16:825-834.
PMID: 33814906
PMC: 8010121.
DOI: 10.2147/COPD.S292666.
